Related Experiment Video
Updated: Jul 4, 2026

Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses
Published on: May 4, 2015
Optimization of the doxycycline-dependent simian immunodeficiency virus through in vitro evolution
Atze T Das1, Bep Klaver, Mireille Centlivre
1Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, The Netherlands. a.t.das@amc.uva.nl
Researchers optimized a doxycycline-dependent simian immunodeficiency virus (SIV) variant through in vitro evolution. This enhanced SIV-rtTA replicates efficiently in cells and macaque PBMCs, maintaining doxycycline control for potential vaccine applications.
Area of Science:
- Virology
- Immunology
- Vaccine Development
Background:
- Live attenuated simian immunodeficiency virus (SIV) vaccination offers protection in macaques.
- Live attenuated human immunodeficiency virus (HIV) vaccines are risky due to potential reversion to pathogenicity.
- A doxycycline (dox)-dependent HIV-1 variant was previously developed for controlled replication.
Purpose of the Study:
- To construct a doxycycline-dependent SIV variant (SIV-rtTA) for safety and efficacy testing in macaques.
- To optimize SIV-rtTA replication efficiency through in vitro viral evolution for macaque studies.
Main Methods:
- Inactivated the native Tat-TAR mechanism and replaced it with a Tet-On regulatory system for dox-dependent replication.
- Optimized SIV-rtTA replication through long-term in vitro viral evolution.
- Analyzed viral genetic changes in TAR and U3 promoter regions.
Main Results:
- Evolved SIV-rtTA variants acquired mutations in TAR and U3 promoter regions.
- These mutations restored the equilibrium of TAR conformations, crucial for efficient replication.
- Optimized SIV-rtTA demonstrated improved replication in T-cell lines and macaque PBMCs without compromising dox-control.
Conclusions:
- In vitro evolution successfully optimized the doxycycline-dependent SIV-rtTA variant.
- The optimized SIV-rtTA is suitable for testing conditionally live virus vaccine strategies.
- This variant serves as a valuable tool for SIV biology and vaccine research.
More Related Videos
13:13Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4+ T Cells Isolated from Rhesus macaques
Published on: September 25, 2018
09:13Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
Related Concept Videos
Viral Mutations
In-vitro Mutagenesis